Star Japanese right-hander Tatsuya Imai signed a three-year deal with the Houston Astros, the team announced on Friday. The deal includes opt-outs after the 2026 and 2027 seasons, the Astros said.

The body of 53-year-old Linda Brown, a Chicago Public Schools teacher who had been missing for over a week, was recovered from Lake Michigan on Monday, police said. A man and a 6-year-old boy were ...

Is Byron Buxton going to be traded this winter? According to one reputable insider, there's a 35% chance the Minnesota Twins deal him. More prominent in the insider's report, however, is that Buxton ...

In a transaction that became official Monday, the Mets, Rangers and Brandon Nimmo all made trades. Nimmo, who owned a no-trade clause, was willing to trade what might have become Mets immortality for ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Within less than two months after the Commission put forward its proposal on a regulation implementing the bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur ...

Among the myriad abilities that humans possess, which ones are uniquely human? Language has been a top candidate at least since Aristotle, who wrote that humanity was “the animal that has language.” ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Recursion ...

Leaders agree to proceed with new 2040 climate target Focus on keeping economy competitive while going green Countries split over pace and cost of emissions cuts Clean transition is a business ...

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...